To our knowledge, till now, there is no/negligible proteomic study regarding identification of the phosphorylated protein in combination of analyzing the differential proteome of CAD and validation of TTR in 200 samples collected prior to PCI treatment. This evidence concerns the gene TTR and coronary artery disorder.